tuftsin has been researched along with Koch's Disease in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (50.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Baranyai, Z; Bősze, S; Dávid, S; Krátký, M; Senoner, Z; Stolaříková, J; Szabó, E; Vinšová, J; Vosátka, R | 1 |
| Bősze, S; Csámpai, A; Gyulai, G; Horváti, K; Kiss, É; Rohonczy, J | 1 |
| Gupta, CM; Haq, W | 1 |
| Agrawal, AK; Gupta, CM | 1 |
1 review(s) available for tuftsin and Koch's Disease
| Article | Year |
|---|---|
Tuftsin-bearing liposomes in treatment of macrophage-based infections.
Topics: Amphotericin B; Animals; Drug Carriers; Drug Delivery Systems; Humans; Leishmaniasis; Liposomes; Macrophages; Malaria; Mycoses; Tuberculosis; Tuftsin | 2000 |
3 other study(ies) available for tuftsin and Koch's Disease
| Article | Year |
|---|---|
In vitro biological evaluation of new antimycobacterial salicylanilide-tuftsin conjugates.
Topics: Animals; Antitubercular Agents; Cell Line; Humans; Mycobacterium; Mycobacterium Infections; Mycobacterium tuberculosis; Rats; Salicylanilides; Tuberculosis; Tuberculosis, Multidrug-Resistant; Tuftsin | 2017 |
Surface Layer Modification of Poly(d,l-lactic- co-glycolic acid) Nanoparticles with Targeting Peptide: A Convenient Synthetic Route for Pluronic F127-Tuftsin Conjugate.
Topics: Antitubercular Agents; Cell Line; Drug Carriers; Drug Delivery Systems; Humans; Monocytes; Mycobacterium tuberculosis; Nanoparticles; Poloxamer; Polylactic Acid-Polyglycolic Acid Copolymer; Surface Properties; Tuberculosis; Tuftsin | 2018 |
Tuftsin-bearing liposomes as antibiotic carriers in treatment of macrophage infections.
Topics: Animals; Anti-Bacterial Agents; Aspergillosis; Drug Carriers; Erythrocytes; Leishmania donovani; Leishmaniasis, Visceral; Liposomes; Macrophages; Mice; Mycobacterium tuberculosis; Neutrophils; Rats; Tuberculosis; Tuftsin | 2005 |